Search

Search results

316 results found

Quantifying patients' preferences on tradeoffs between mortality risk and reduced need for target vessel revascularization for claudication.

Publication: Journal Article

Reed, Shelby D, Jessie Sutphin, Matthew J Wallace, Juan Marcos Gonzalez, Jui-Chen Yang, Reed Johnson, Jennifer Tsapatsaris, et al. 2024. “Quantifying Patients’ Preferences on Tradeoffs Between Mortality Risk and Reduced Need for Target Vessel Revascularization for Claudication.”. Vascular Medicine (London, England) 29 (6): 675-83.

Asymptomatic severe degenerative mitral regurgitation.

Publication: Journal Article

Björn, Rikhard, Jordan B Strom, Guy Lloyd, and Sanjeev Bhattacharyya. 2024. “Asymptomatic Severe Degenerative Mitral Regurgitation.”. Heart (British Cardiac Society) 111 (2): 47-54.

Artificial intelligence-enabled electrocardiogram for mortality and cardiovascular risk estimation: a model development and validation study.

Publication: Journal Article

Sau, Arunashis, Libor Pastika, Ewa Sieliwonczyk, Konstantinos Patlatzoglou, Antônio H Ribeiro, Kathryn A McGurk, Boroumand Zeidaabadi, et al. 2024. “Artificial Intelligence-Enabled Electrocardiogram for Mortality and Cardiovascular Risk Estimation: A Model Development and Validation Study.”. The Lancet. Digital Health 6 (11): e791-e802.

Facilitating Efficient and Ethical Trials at the Intersection of Research and Clinical Care.

Publication: Journal Article

Lynch, Holly Fernandez, and Daniel B Kramer. 2025. “Facilitating Efficient and Ethical Trials at the Intersection of Research and Clinical Care.”. JAMA 333 (1): 34-36.

Anna Krawisz, MD

Person: Faculty Physician Investigator

Anna Krawisz, MD is an Instructor in Medicine at Harvard Medical School and a cardiologist and vascular medicine specialist at Beth Israel Deaconess Medical Center (BIDMC). Her research interests include disparities in care for peripheral artery disease and interventional therapies for peripheral...

Lichen Liang, PhD

Person: Lead Statistician

Lichen Liang, PhD, is the Lead Biostatistician at the Smith Center. He has over seven years of experience in the field of healthcare research and analytics. He was a Data Scientist at Tufts Medical Center and a Research Scientist at Massachusetts General Hospital. His focus has been on developing...

Mortality and readmissions after ventricular tachycardia ablation: An analysis of inpatient and outpatient state databases.

Publication: Journal Article

Brodeur, Peter G, Enrico G Ferro, Timothy G Maher, Jonathan W Waks, Andre D’Avila, ZhaoNian Zheng, Peter J Zimetbaum, et al. 2025. “Mortality and Readmissions After Ventricular Tachycardia Ablation: An Analysis of Inpatient and Outpatient State Databases.”. Heart Rhythm.

Search

Search results

Quantifying patients' preferences on tradeoffs between mortality risk and reduced need for target vessel revascularization for claudication.

Asymptomatic severe degenerative mitral regurgitation.

Artificial intelligence-enabled electrocardiogram for mortality and cardiovascular risk estimation: a model development and validation study.

Facilitating Efficient and Ethical Trials at the Intersection of Research and Clinical Care.

Anna Krawisz, MD

Lichen Liang, PhD

Publications Archive

Awards, Contests, and Recognition

News Roundup: October - December 2024

Mortality and readmissions after ventricular tachycardia ablation: An analysis of inpatient and outpatient state databases.